结直肠癌
免疫系统
医学
微卫星不稳定性
免疫疗法
免疫检查点
肿瘤科
癌症免疫疗法
内科学
癌症
癌症研究
免疫学
生物
等位基因
基因
微卫星
生物化学
作者
Shuji Ogino,Marios Giannakis
出处
期刊:The Lancet
[Elsevier BV]
日期:2018-05-01
卷期号:391 (10135): 2084-2086
被引量:55
标识
DOI:10.1016/s0140-6736(18)30953-x
摘要
Immunotherapies targeting immune checkpoints such as CTLA4, PDCD1 (PD-1), and CD274 (PD-L1) have revolutionised oncology. 1 Basile D Garattini SK Bonotto M et al. Immunotherapy for colorectal cancer: where are we heading?. Expert Opin Biol Ther. 2017; 17: 709-721 Crossref PubMed Scopus (73) Google Scholar High-level microsatellite instability (MSI-high) caused by mismatch repair deficiency is routinely used as a biomarker to predict response to immune-checkpoint blockade. 2 Le DT Hubbard-Lucey VM Morse MA et al. A blueprint to advance colorectal cancer immunotherapies. Cancer Immunol Res. 2017; 5: 942-949 Crossref PubMed Scopus (44) Google Scholar MSI-high status in colorectal carcinoma correlates with tumour neoantigen loads, which in turn correlate with immune response. 3 Giannakis M Mu XJ Shukla SA et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 2016; 15: 857-865 Summary Full Text Full Text PDF PubMed Scopus (474) Google Scholar Combined analysis of tumoural and immune factors (eg, the so-called Tumour Immunity in the MicroEnvironment [TIME] classification) could be a new cancer classification system. However, immune response measurements have not been used as robust biomarkers of pathology in clinical practice. Along with the inherent complexity of the immune system, difficulty in reproducibly assessing immune cells remains a cause of this gap. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyThe Immunoscore provides a reliable estimate of the risk of recurrence in patients with colon cancer. These results support the implementation of the consensus Immunoscore as a new component of a TNM-Immune classification of cancer. Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI